Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:32:59.940Z.
Calculation as of: 2026-10-06T17:32:59.940Z.
Quote observation: 2026-10-06T17:30:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 347a41eedf46a91d1f1a35dde2c997a021a555167078676fef94c90a8032fb0d
EARNINGS YIELD
N/A
MiniMed Group, Inc. Common Stock
Market Cap
$5.49B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.28B
Earnings Yield
N/A
TTM Avg
12.04%
3Y Avg
12.04%
5Y Avg
12.04%
Market Cap
$5.26B
Earnings Yield
3.10%
TTM Avg
1.86%
3Y Avg
1.49%
5Y Avg
1.88%
Market Cap
$5.74B
Earnings Yield
1.30%
TTM Avg
1.27%
3Y Avg
1.97%
5Y Avg
7.52%
Market Cap
$5.22B
Earnings Yield
N/A
TTM Avg
6.02%
3Y Avg
4.00%
5Y Avg
4.00%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.49B | N/A | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | N/A | 0.29% | 1.14% | 1.23% |
| CG Oncology Inc. (CGON)vs › | $5.61B | N/A | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.30B | 3.00% | 3.81% | 2.64% | 2.45% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.28B | N/A | 12.04% | 12.04% | 12.04% |
| Sotera Health Company (SHC)vs › | $5.26B | 3.10% | 1.86% | 1.49% | 1.88% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.74B | 1.30% | 1.27% | 1.97% | 7.52% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | N/A | 6.02% | 4.00% | 4.00% |
| Kodiak Sciences Inc. (KOD)vs › | $5.77B | N/A | N/A | N/A | N/A |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute